Gritstone Oncology shares nearly quadruple after receiving NIH support on vaccine trial
January 20, 2021 at 20:49 PM EST
Gritstone Oncology CEO Andrew Allen said the drugmaker hopes their potential coronavirus vaccine could help mitigate the spread of Covid-19 variants.
